Evidence-Based Recommendation : FDA-approved Ozempic remains the gold standard for semaglutide therapy, offering the best combination of proven efficacy, safety oversight, and long-term support for patients with diabetes and weight management goals
For these people, oral BPC-157 offers a practical alternative that may still provide benefit, particularly when combined with newer arginate formulations claiming 90% or better absorption
Researchers are still looking into whether this means certain oral medications wont be as effective
Widespread adoption, in turn, would lead to the first downtick in the U.S
Whether B12 in a mixed solution (rather than a chemical conjugate) provides the same benefit is unconfirmed in controlled human studies
Based on class effects observed with approved agents and general clinical reasoning, certain patient groups may warrant closer monitoring during any future clinical use of retatrutide